These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 2439642)
1. Circulating antibodies to mouse laminin in Chagas disease, American cutaneous leishmaniasis, and normal individuals recognize terminal galactosyl(alpha 1-3)-galactose epitopes. Towbin H; Rosenfelder G; Wieslander J; Avila JL; Rojas M; Szarfman A; Esser K; Nowack H; Timpl R J Exp Med; 1987 Aug; 166(2):419-32. PubMed ID: 2439642 [TBL] [Abstract][Full Text] [Related]
2. Serological activity against galactosyl-alpha(1-3)galactose in sera from patients with several kinetoplastida infections. Avila JL; Rojas M; Towbin H J Clin Microbiol; 1988 Jan; 26(1):126-32. PubMed ID: 2449451 [TBL] [Abstract][Full Text] [Related]
3. Antibodies to mouse laminin in patients with systemic sclerosis (scleroderma) recognize galactosyl (alpha 1-3)-galactose epitopes. Gabrielli A; Candela M; Ricciatti AM; Caniglia ML; Wieslander J Clin Exp Immunol; 1991 Dec; 86(3):367-73. PubMed ID: 1721011 [TBL] [Abstract][Full Text] [Related]
4. Antibodies to basement membrane protein nidogen in Chagas' disease and American cutaneous leishmaniasis. Avila JL; Rojas M; Velazquez-Avila G; von der Mark H; Timpl R J Clin Microbiol; 1986 Nov; 24(5):775-8. PubMed ID: 2429987 [TBL] [Abstract][Full Text] [Related]
5. Characterization of a natural human antibody with anti-galactosyl(alpha 1-2)galactose specificity that is present at high titers in chronic Trypanosoma cruzi infection. Avila JL; Rojas M; Velazquez-Avila G Am J Trop Med Hyg; 1992 Oct; 47(4):413-21. PubMed ID: 1279994 [TBL] [Abstract][Full Text] [Related]
6. Direct lysis of Trypanosoma cruzi: a novel effector mechanism of protection mediated by human anti-gal antibodies. Gazzinelli RT; Pereira ME; Romanha A; Gazzinelli G; Brener Z Parasite Immunol; 1991 Jul; 13(4):345-56. PubMed ID: 1717927 [TBL] [Abstract][Full Text] [Related]
7. American Leishmania spp. and Trypanosoma cruzi: galactosyl alpha(1-3) galactose epitope localization by colloidal gold immunocytochemistry and lectin cytochemistry. Bretaña A; Avila JL; Contreras-Bretaña M; Tapia FJ Exp Parasitol; 1992 Feb; 74(1):27-37. PubMed ID: 1370418 [TBL] [Abstract][Full Text] [Related]
8. High antibody levels against mouse laminin with specificity for galactosyl-(alpha 1-3)galactose in patients with inner ear diseases. Klein R; Timpl R; Zanetti FR; Plester D; Berg PA Ann Otol Rhinol Laryngol; 1989 Jul; 98(7 Pt 1):537-42. PubMed ID: 2473672 [TBL] [Abstract][Full Text] [Related]
10. A galactosyl(alpha 1-3)mannose epitope on phospholipids of Leishmania mexicana and L. braziliensis is recognized by trypanosomatid-infected human sera. Avila JL; Rojas M J Clin Microbiol; 1990 Jul; 28(7):1530-7. PubMed ID: 1696285 [TBL] [Abstract][Full Text] [Related]
11. Anti-laminin and specific antibodies in acute Chagas disease. Gazzinelli R; Galvão LM; Dias JC; Gazzinelli G; Brener Z Trans R Soc Trop Med Hyg; 1988; 82(4):574-6. PubMed ID: 3151413 [TBL] [Abstract][Full Text] [Related]
12. [Levels of anti-Gal antibodies in persons infected and non-infected with Trypanosoma cruzi. Probably induced by bacteria and by the parasite]. González J; Ramírez C; Seguel X; Gutiérrez B; Manque P; Porcile P; Neira I; Sagua H Bol Chil Parasitol; 1995; 50(1-2):3-9. PubMed ID: 8573266 [TBL] [Abstract][Full Text] [Related]
13. Changes in isotype composition and antigen recognition of anti-Trypanosoma cruzi antibodies from acute to chronic Chagas disease. Umezawa ES; Shikanai-Yasuda MA; Stolf AM J Clin Lab Anal; 1996; 10(6):407-13. PubMed ID: 8951611 [TBL] [Abstract][Full Text] [Related]
14. Lytic anti-alpha-galactosyl antibodies from patients with chronic Chagas' disease recognize novel O-linked oligosaccharides on mucin-like glycosyl-phosphatidylinositol-anchored glycoproteins of Trypanosoma cruzi. Almeida IC; Ferguson MA; Schenkman S; Travassos LR Biochem J; 1994 Dec; 304 ( Pt 3)(Pt 3):793-802. PubMed ID: 7818483 [TBL] [Abstract][Full Text] [Related]
15. Antibodies to laminin in American cutaneous leishmaniasis. Avila JL; Rojas M; Rieber M Infect Immun; 1984 Jan; 43(1):402-6. PubMed ID: 6418660 [TBL] [Abstract][Full Text] [Related]
16. Immunogenic Gal alpha 1----3Gal carbohydrate epitopes are present on pathogenic American Trypanosoma and Leishmania. Avila JL; Rojas M; Galili U J Immunol; 1989 Apr; 142(8):2828-34. PubMed ID: 2467941 [TBL] [Abstract][Full Text] [Related]
17. Potential use of synthetic α-galactosyl-containing glycotopes of the parasite Trypanosoma cruzi as diagnostic antigens for Chagas disease. Ashmus RA; Schocker NS; Cordero-Mendoza Y; Marques AF; Monroy EY; Pardo A; Izquierdo L; Gállego M; Gascon J; Almeida IC; Michael K Org Biomol Chem; 2013 Sep; 11(34):5579-83. PubMed ID: 23863943 [TBL] [Abstract][Full Text] [Related]
18. A complement-fixing antigen from Trypanosoma cruzi grown in cell cultures. Neva FA; Gam AA Am J Trop Med Hyg; 1977 Jan; 26(1):37-46. PubMed ID: 65921 [TBL] [Abstract][Full Text] [Related]
19. Anti-alpha-galactosyl antibodies in chagasic patients. Possible biological significance. Milani SR; Travassos LR Braz J Med Biol Res; 1988; 21(6):1275-86. PubMed ID: 2471563 [TBL] [Abstract][Full Text] [Related]
20. Autoantibodies in the sera of Trypanosoma cruzi-infected individuals with or without clinical Chagas disease. Unterkircher C; Avrameas S; Ternynck T J Clin Lab Anal; 1993; 7(1):60-9. PubMed ID: 8426274 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]